Somru BioScience to present and exhibit at WRIB Conference in Philadelphia

Charlottetown, PE, CANADA, March 26, 2018, 08:30 ET

Somru BioScience Inc. (Somru), a leading biosimilar solution provider, today announced it will exhibit and present at    the 12th WRIB Workshop on Recent Issues on Bioanalysis Conference, April 9th- 13th, in Philadelphia, PA.                      WRIB is a highly regarded industry forum where regulators and industry convene to accelerate drug development, including biosimilars, in the fields of bioanalysis, biomarkers, and immunogenicity. The company will be in Booth #03 for the duration of the show.

Somru has developed a portfolio of reagents, tools, solutions and a knowledge database to enable companies to capitalize on biosimilar opportunities. Somru has comprehensive expertise and solutions to significantly reduce both the time and cost of biosimilar development programs.

Somru Scientists will be presenting a novel approach to development of competitive ligand binding assays for the detection of neutralizing antibodies against ranibizumab and bevacizumab. Poster (PO2) will be presented on          Thursday, April 12th, in the Exhibit Hall.

Somru also announces previews at their booth, with live demonstrations, of its soon-to-be-released immunogenicity software, Aegyris. This first-of-a-kind web-based application will enable researchers to perform immunogenicity validation for biologics and biosimilars assays in a streamlined quality manner. The software has the potential to reduce the cost and timeline for complex biosimilar immunogenicity validation by 50%.

Somru BioScience Inc. is a leading provider for biosimilar development tools and solutions. Somru has developed a portfolio of reagents, ELISA kits, innovative biosimilar comparability tools and a knowledge database to enable companies to significantly reduce the cost and timeline for biosimilar development. Somru technologies reduce early development risk by identifying clinically meaningful differences prior to running expensive clinical trials.

Somru is headquartered in Charlottetown, Canada, and has customers throughout North and South America, Europe, Australia, and Asia.


If you would like more information on about this topic, please contact Susan Holland at or call +1 902.367.4322.

Contact information

Somru BioScience Inc.
19 Innovation Way
BioCommons Research Park
Prince Edward Island, C1E 0B7